跳至主要内容
临床试验/NCT04508764
NCT04508764终止不适用

Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Washington University School of Medicine2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2021年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
96
试验地点
2
主要终点
Proband-reported cascade testing rates of first-degree relatives

研究概览

简要总结

The purpose of this research study is to learn how cancer care providers can help their patients communicate the need for genetic testing in families with inherited cancer syndromes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documentation of HBOC or Lynch-associated "pathogenic/ likely pathogenic" mutation per American College of Medical Genetics and Genomics criteria (1)
  • Diagnosis of one or more invasive cancers: epithelial ovarian, fallopian tube, primary peritoneal, breast, colorectal, endometrial
  • Mutation listed in NCCN guidelines with at least Category 2A evidence for intervention
  • Over the age of 18
  • Psychological ability and general health that permits completion of study requirements and follow-up
  • Willingness to complete follow-up surveys in person, electronically, or by telephone for up to 6 months

排除标准

  • "Variant of undetermined significance," "likely benign" or "benign" variant per ACMGG criteria

结局指标

主要结局

Proband-reported cascade testing rates of first-degree relatives

时间窗: From start of study through completion of 6 month follow-up (estimated to be 18 months)

-For each proband, this testing rate is defined as the number of first-degree relatives tested divided by the number of living first-degree relatives age-appropriate for testing, as determined by family surveys done by the proband. The investigators will calculate mean cascade genetic testing rates for both conditions (Usual Care and FACTT intervention).

Family member-reported cascade testing rates

时间窗: From start of study through completion of 6 month follow-up (estimated to be 18 months)

-This testing rate is defined by the number of family members tested divided by the number of living family members age-appropriate for testing

Number of primary barriers to genetic testing for family members

时间窗: From start of study through completion of 6 month follow-up (estimated to be 18 months)

-The Family Member survey will assess experience with considering testing themselves, decisional regret regarding genetic testing, and if they have tested positive

Number of primary barriers to genetic testing for first-degree relatives

时间窗: From start of study through completion of 6 month follow-up (estimated to be 18 months)

-The Cascade Genetic Testing survey will assess knowledge, perception, and personal experience with sharing germline mutation information with first-degree relatives

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验